Clinical Research Directory
Browse clinical research sites, groups, and studies.
Multicenter Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis.
Sponsor: Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Summary
Phase III, multicenter, randomized, open-label, multicenter clinical trial comparing treatment with allogeneic mesenchymal cells versus autologous mesenchymal cells and versus active control with hyaluronic acid in patients with knee osteoarthritis.
Official title: Phase III, Multicenter, Randomized, Open-label Clinical Trial Comparing Treatment with Allogeneic Mesenchymal Cells Versus Autologous Mesenchymal Cells and Versus Active Control with Hyaluronic Acid in Patients with Knee Osteoarthritis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
124
Start Date
2021-05-26
Completion Date
2026-05
Last Updated
2024-11-29
Healthy Volunteers
No
Conditions
Interventions
Autologous MSCs
Intra-articular injection 40 million/4 ml.
Allogenic MSCs
Intra-articular injection 40 million/4 ml.
Hyaluronic Acid
Intra-articular injection 60mg / 3 ml .
Locations (8)
Hospital Clinic
Barcelona, Spain
Hospital Clínico Universitario San Carlos
Madrid, Spain
Hospital Fundación Jiménez Díaz
Madrid, Spain
Hospital Gregorio Marañón
Madrid, Spain
Hospital Universitario Virgen de la Victoria
Málaga, Spain
Hospital Universitario Virgen de la Arrixaca
Murcia, Spain
Clínica Universidad de Navarra
Pamplona, Spain
Complejo Asistencial Universitario de Salamanca
Salamanca, Spain